Vicarious Surgical Inc. ( (RBOT) ) has released its Q4 earnings. Here is a breakdown of the information Vicarious Surgical Inc. presented to its investors.
Vicarious Surgical Inc. is a next-generation robotics technology company focused on transforming robotic surgery to improve patient outcomes and reduce healthcare costs. The company has developed a unique surgical approach using proprietary human-like robots for minimally invasive procedures.
In its latest earnings report, Vicarious Surgical announced the completion of its Version 1.0 system integration and progress towards its first clinical use. The company also achieved its 2024 cash burn guidance and set a 2025 cash burn guidance of $50 million.
Key financial highlights include a decrease in operating expenses for both the fourth quarter and full year 2024 compared to 2023. The company reported a full-year adjusted net loss of $63.3 million, an improvement from the previous year’s $76.3 million. Strategic partnerships with major health institutions and advancements in clinical trial readiness were also noted as significant achievements.
Looking forward, Vicarious Surgical remains focused on preparing for its first clinical patients in 2025, building inventory for essential testing, and securing necessary approvals. The company aims to demonstrate the value of its surgical system in a live clinical setting, reflecting a positive outlook for the upcoming year.